DIP Episode 476 - USMLE Step 2/3 Rapid Review Series 100

Source / episode info

• Episode: 476
• Title: Divine Intervention Episode 476: USMLE Step 2/3 Rapid Review Series 100
• Published: 2023-08-16
• Source: Episode page

One-liner

This episode provides a rapid review of genetic sex development disorders (AIS vs. MRKH), microcytic anemias (IDA, Thalassemia, Lead Poisoning), and macrocytic/hemolytic anemia differentiation (B12 vs. Folate deficiency).

High-yield summary

• Androgen Insensitivity Syndrome (AIS): Genotypically 46 XY; phenotypically female. Testes are present, producing Anti-Müllerian Hormone (AMH) and Müllerian Inhibiting Factor (MIF), leading to the absence of Müllerian derivatives (uterus, fallopian tubes). The defect is in the testosterone receptor, causing lack of masculinization outside.
• MRKH Syndrome: Genotypically 46 XX; phenotypically female. Ovaries are intact and functional, producing estrogen and androgens normally. Lack of Müllerian derivatives occurs for unknown reasons.
• Iron Deficiency Anemia (IDA): Characterized by microcytosis, low ferritin, high Total Iron Binding Capacity (TIBC), and low transferrin saturation (TSAT). Suspected in cases of GI blood loss.
• B12 vs. Folate Deficiency: Both cause macrocytic anemia due to impaired DNA synthesis. B12 deficiency is uniquely associated with elevated methylmalonic acid (MMA) and peripheral neuropathy, while folate deficiency only elevates homocysteine.
• Anemia of Chronic Disease (ACD): Characterized by inflammation leading to iron sequestration in bone marrow macrophages, resulting in high ferritin but low TIBC/TSAT.

Learning objectives

• Differentiate between Androgen Insensitivity Syndrome (AIS) and Mayer-Rokitansky-Küster-Hauser syndrome (MRKH).
• Interpret laboratory findings to distinguish Iron Deficiency Anemia, Thalassemia, and Anemia of Chronic Disease.
• Recognize the unique biochemical markers associated with Vitamin B12 deficiency versus folate deficiency.
• Understand the pathophysiology leading to microcytic anemia in various conditions (e.g., iron depletion, impaired globin synthesis).
• Correlate clinical signs (neuropathy, amenorrhea) with underlying genetic or nutritional deficiencies.

Board exam buzzwords

Rapid review table

Board-speak -> diagnosis

Differential diagnosis / distinguishing features

Microcytic Anemias: IDA vs Thalassemia vs Lead Poisoning

Macrocytic Anemias: B12 Deficiency vs Folate Deficiency

Management pearls

• For suspected iron deficiency anemia, the initial workup must include checking ferritin, TIBC, and TSAT to confirm depletion status.
• In patients with primary amenorrhea, always rule out both AIS (46 XY) and MRKH (46 XX) by performing karyotyping and assessing secondary sexual characteristics.
• When managing B12 deficiency, the neurological symptoms must be addressed aggressively; supplementation should be given parenterally (IM/IV) initially due to poor oral absorption.
• For suspected lead poisoning, GI symptoms are common, but also look for encephalopathy or peripheral neuropathy, which requires immediate chelation therapy.

Don't miss

Integration & clinical reasoning

• Endocrinology & Genetics: The development of secondary sexual characteristics is governed by the interplay between estrogen (breast development), androgens (pubic/axillary hair), and the presence of Müllerian derivatives, making AIS/MRKH a critical endocrine differential.
• Hematology & Metabolism: Microcytic anemia can result from multiple causes—either impaired synthesis of globin chains (thalassemia, IDA) or metabolic poisoning (lead). The underlying mechanism often involves disrupting heme synthesis pathways.

Concept connections / cross-references

• For detailed information on the hormonal control of secondary sexual characteristics and reproductive anatomy: [Episode 12]
• For comprehensive review of anemia types and iron metabolism: [Episode 37]

High-yield association table

Key terms glossary

Study optimization

Question pattern recognition

• Primary Amenorrhea: Always differentiate between AIS (46 XY, testes present) and MRKH (46 XX, ovaries intact). The pubic hair pattern is the key differentiator.
• Microcytic Anemia Workup: If iron studies are abnormal (low ferritin/high TIBC), suspect IDA. If HbA2 is elevated, suspect Thalassemia. If inflammation is present, suspect ACD.
• B12 Deficiency Clue: The combination of macrocytosis AND peripheral neuropathy strongly suggests B12 deficiency and requires immediate investigation for MMA elevation.

Test yourself

Common mistakes to avoid

Common traps

OMM / COMLEX integration

• Spleen & Reticuloendothelial Innervation (T5–T9): The spleen and bone marrow microvasculature are influenced by sympathetic outflow from the celiac plexus (T5–T9, left side). Somatic dysfunction at the mid-thoracic paraspinal levels reflects splenic hematologic stress.
• Lymphatic Return in Malignancy & Lymphedema: Post-surgical or post-radiation lymphedema requires gentle proximal-to-distal decongestion starting with opening the thoracic inlet and axillary fascial diaphragms before addressing peripheral extremities. Avoid vigorous direct pumping over known active tumor sites.
• Bone Marrow Pain & Myofascial Somatic Dysfunction: Patients with hematologic expansion or skeletal metastases develop reactive hypertonicity in surrounding postural stabilizers (quadratus lumborum, erector spinae). Gentle indirect techniques (counterstrain, myofascial release) provide substantial pain relief without risking pathologic fractures.